Armata Pharmaceuticals | 10-Q:季度报表
Armata Pharmaceuticals | 8-K:Armata Pharmaceuticals公布2024年第一季度业绩并提供公司最新情况
Armata Pharmaceuticals | ARS:年度报告
Armata Pharmaceuticals | DEF 14A:股东委托书决议
Armata Pharmaceuticals | 8-K:重大事件
Armata Pharmaceuticals | 10-K:年度报表
Armata Pharmaceuticals | 8-K:Armata Pharmicals公布2023年第四季度和全年业绩并提供公司最新情况
Armata Pharmaceuticals | 4:持股变动声明-董事 PATTI JOSEPH M
Armata Pharmaceuticals | 4:持股变动声明-董事 Kramer Robin
Armata Pharmaceuticals | 4:持股变动声明-董事 Peterson Todd C.
Armata Pharmaceuticals | 4:持股变动声明-高管 Rychlik Richard
Armata Pharmaceuticals | 4:持股变动声明-董事 Schlesinger Sarah J.
Armata Pharmaceuticals | 4:持股变动声明-董事 Haimovitz Jules
Armata Pharmaceuticals | 4:持股变动声明-董事 Odysseas Kostas D
Armata Pharmaceuticals | 4:持股变动声明-高管 Birx Deborah
Armata Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-Innoviva, Inc(85.3%),Innoviva Strategic Opportunities LLC(62.1%)
Armata Pharmaceuticals | 8-K:重大事件
Armata Pharmaceuticals | S-8:员工福利计划证券登记
Armata Pharmaceuticals | 4:持股变动声明-董事 Schlesinger Sarah J.
Armata Pharmaceuticals | 4:持股变动声明-董事 Peterson Todd C.
暂无数据